Overview
Background
Associate professor David Vesey is a leading research scientist in The University of Queensland Centre for Kidney Disease Research at the Translational Research Institute and a senior scientist within the Department of Kidney and Transplant Services at the Princess Alexandra Hospital. He is a graduate of Kings College and Imperial Collage, London University. Postdoctoral studies were at London University and The University of Queensland.
His main research interests are in the area of kidney tubulointerstitial fibrosis, inflammation and cancer – particularly the role that cytokines and growth factors play in these processes. Current projects include the role of protease activated receptor-2 in kidney inflammation and fibrosis, and the mechanism of heavy metal toxicity in the kidney. He manages the Princess Alexandra Hospital Endotoxin Testing Service which routinely tests samples from dialysis units throughout Queensland.
Availability
- Associate Professor David Vesey is:
- Available for supervision
Fields of research
Qualifications
- Bachelor of Biochemistry, King's College London
- Doctor of Philosophy of Gastroenterology and Hepatology, Imperial College London
Works
Search Professor David Vesey’s works on UQ eSpace
2008
Conference Publication
Recombinant human erythropoietin reduces ischemic acute kidney injury but does not stop progression to chronic kidney disease
Bennett, N., Colditz, P., Gobe, G. C., Johnson, D., Patel, J. and Vesey, D. A. (2008). Recombinant human erythropoietin reduces ischemic acute kidney injury but does not stop progression to chronic kidney disease. 44th Annual Scientific Meeting of the Australian and New Zealand Society of Nephrology, Newcastle, Australia, 6-10 September 2008. HOBOKEN: Australian and New Zealand Society of Nephrology (ANZSN). doi: 10.1111/j.1440-1797.2008.001013.x
2007
Journal Article
Erythropoietin reduces cisplatin-induced apoptosis in renal carcinoma cells via a PKC dependent pathway
Li, Jun, Vesey, David A., Johnson, David W. and Gobe, Glenda C. (2007). Erythropoietin reduces cisplatin-induced apoptosis in renal carcinoma cells via a PKC dependent pathway. Cancer Biology Therapy, 6 (12), 1944-1950. doi: 10.4161/cbt.6.12.4975
2007
Journal Article
Proinflammatory and proliferative responses of human proximal tubule cells to PAR-2 activation
Vesey, David A., Kruger, Wade A., Poronnik, Philip, Gobe, Glenda C. and Johnson, David W. (2007). Proinflammatory and proliferative responses of human proximal tubule cells to PAR-2 activation. American Journal of Physiology: Renal Physiology, 293 (5), F1441-F1449. doi: 10.1152/ajprenal.00088.2007
2007
Journal Article
Therapeutic value of orally administered silibinin in renal cell carcinoma: Manipulation of insulin-like growth factor binding protein-3 levels
Cheung, Catherine W., Taylor, Paul J., Kirkpatrick, Carl M.J., Vesey, David A., Gobe, Glenda C., Winterford, Clay, Nicol, David L. and Johnson, David W. (2007). Therapeutic value of orally administered silibinin in renal cell carcinoma: Manipulation of insulin-like growth factor binding protein-3 levels. BJU International, 100 (2), 438-444. doi: 10.1111/j.1464-410X.2007.07012.x
2007
Journal Article
Apoptosis of tubulointerstitial chronic inflammatory cells in progressive renal fibrosis after cancer therapies
Yang, Tao, Vesey, David A., Johnson, David W., Wei, Ming Q. and Gobe, Glenda C. (2007). Apoptosis of tubulointerstitial chronic inflammatory cells in progressive renal fibrosis after cancer therapies. Translational Research, 150 (1), 40-50. doi: 10.1016/j.trsl.2007.01.006
2007
Journal Article
Isolation, propagation and characterization of primary tubule cell culture from human kidney (Methods in Renal Research)
Qi, Weier, Johnson, David W., Vesey, David A., Pollock, Carol A. and Chen, Xinming (2007). Isolation, propagation and characterization of primary tubule cell culture from human kidney (Methods in Renal Research). Nephrology, 12 (2), 155-159. doi: 10.1111/j.1440-1797.2007.00779.x
2007
Journal Article
Silibinin inhibits renal cell carcinoma via mechanisms that are independent if insulin-like growth factor-binding protein 3
Cheung, Catherine W., Vesey, David A., Nicol, David L. and Johnson, David W. (2007). Silibinin inhibits renal cell carcinoma via mechanisms that are independent if insulin-like growth factor-binding protein 3. BJU International, 99 (2), 454-460. doi: 10.1111/j.1464-410X.2007.06571.x
2007
Journal Article
Potential physiological and pathophysiological roles for protease-activated receptor-2 in the kidney
Vesey, David A., Hooper, John D., Gobe, Glenda C. and Johnson, David W. (2007). Potential physiological and pathophysiological roles for protease-activated receptor-2 in the kidney. Nephrology, 12 (1), 36-43. doi: 10.1111/j.1440-1797.2006.00746.x
2007
Conference Publication
Erythropoietin: Novel applications beyond anaemia treatment
Vesey, D. A., Gobe, G. C. and Johnson, D. W. (2007). Erythropoietin: Novel applications beyond anaemia treatment. 2nd International Conference of Naresuan University, Phitsanulok, Thailand, 27-28 July, 2007.
2007
Conference Publication
The effect of recombinant human erythropoietin (rhEPO) in renal cell carcinoma (RCC) chemotherapy
Li, J., Vesey, D. A., Johnson, D. W. and Gobe, G. C. (2007). The effect of recombinant human erythropoietin (rhEPO) in renal cell carcinoma (RCC) chemotherapy. 32nd Lorne Conference on Protein Structure and Function, Lorne, Victoria, Australia, 4-8 February 2007. Lorne, Vic., Australia:
2007
Conference Publication
The effect of recombinant human erythropoietin (rhEPO) in renal cell carcinoma (RCC) chemotherapy
Li, J., Vesey, D. A., Johnson, D. W. and Gobe, G. C. (2007). The effect of recombinant human erythropoietin (rhEPO) in renal cell carcinoma (RCC) chemotherapy. World Congress of Nephrology, Rio De Janeiro, Brazil, 21-25 April , 2007. International Society of Nephrology (ISN).
2006
Journal Article
Novel renoprotective actions of erythropoietin: New uses for an old hormone
Johnson, David W., Forman, Colin and Vesey, David A. (2006). Novel renoprotective actions of erythropoietin: New uses for an old hormone. Nephrology, 11 (4), 306-312. doi: 10.1111/j.1440-1797.2006.00585.x
2006
Journal Article
Delayed administration of darbepoetin or erythropoietin protects against ischemic acute renal injury and failure
Johnson, D. W., Pat, B., Vesey, D. A., Guan, Z., Endre, Z. and Gobe, G. C. (2006). Delayed administration of darbepoetin or erythropoietin protects against ischemic acute renal injury and failure. Kidney International, 69 (10), 1806-1813. doi: 10.1038/sj.ki.5000356
2006
Conference Publication
PKC regulation of the cyclin dependent kinase inhibitor p21 in normal kidney versus kidney cancer cells
Li, Jun, Vesey, David and Gobe, Glenda (2006). PKC regulation of the cyclin dependent kinase inhibitor p21 in normal kidney versus kidney cancer cells. American Society of Nephrology Renal Research Week, San Diego, USA, 2006. ASN.
2006
Conference Publication
Resistance to cancer treatments in renal cell carcinomas: Discovering novel apoptotic pathways
Rajandram, R ., Pat, B., Li, J., Percy, C. J., Vesey, D., Johnson, D. W. and Gobe, G. C. (2006). Resistance to cancer treatments in renal cell carcinomas: Discovering novel apoptotic pathways. Australian and New Zealand Society of Nephrology Annual Scientific Meeting, Melbourne, Australia, 14-18 August 2006. Richmond, Vic., Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/j.1440-1797.2006.00656.x
2006
Conference Publication
PAR-2 Is expressed by human proximal tubule cells and mediates pro-inflammatory and proliferative responses
Gobe, G. C., Johnson, D. W., Kruger, W., Poronnik, P. and Vesey, D. A. (2006). PAR-2 Is expressed by human proximal tubule cells and mediates pro-inflammatory and proliferative responses. Renal Week 2006: American Society of Nephrology Annual Meeting, San Diego, California, U.S., 14 - 19 November, 2006. American Society of Nephrology.
2006
Conference Publication
PKC regulation of the cyclin dependent kinase (cdk) inhibitor p21 in normal kidney versus kidney cancer cells
Li, J., Vesey, D. and Gobe, G. (2006). PKC regulation of the cyclin dependent kinase (cdk) inhibitor p21 in normal kidney versus kidney cancer cells. Australia and New Zealand Society of Nephrology and Renal Society of Australasia Annual Scientific Conference, Melbourne, Australia, 14–19 August 2006.
2006
Conference Publication
Protective effect of Angelica sinensis on renal vascular endothelial cell damage induced by oxidative stress
Yamada, M., Vesey, D., Johnson, D. W. and Gobe, G. (2006). Protective effect of Angelica sinensis on renal vascular endothelial cell damage induced by oxidative stress. ANZSN 2006: 42nd Australia and New Zealand Society of Nephrology and Renal Society of Australasia Annual Scientific Conference, Melbourne, Australia, 14-19 August 2006. Carlton, Vic., Australia: Blackwell Science. doi: 10.1111/j.1440-1797.2006.00656.x
2005
Journal Article
Thrombin stimulates proinflammatory and proliferative responses in primary cultures of human proximal tubule cells
Vesey, David A., Cheung, Catherine W., Kruger, Wade A., Poronnik, Philip, Gobe, Glenda and Johnson, David W. (2005). Thrombin stimulates proinflammatory and proliferative responses in primary cultures of human proximal tubule cells. Kidney International, 67 (4), 1315-1329. doi: 10.1111/j.1523-1755.2005.00209.x
2005
Journal Article
Role of protein kinase C and oxidative stress in interleukin-1β-induced human proximal tubule cell injury and fibrogenesis
Vesey, David A., Cheung, Catherine, Endre, Zoltan, Gobe, Glenda and Johnson, David W. (2005). Role of protein kinase C and oxidative stress in interleukin-1β-induced human proximal tubule cell injury and fibrogenesis. Nephrology, 10 (1), 73-80. doi: 10.1111/j.1440-1797.2005.00363.x
Funding
Past funding
Supervision
Availability
- Associate Professor David Vesey is:
- Available for supervision
Looking for a supervisor? Read our advice on how to choose a supervisor.
Supervision history
Completed supervision
-
2025
Doctor Philosophy
Exploring Magnetic Resonance for Differentiating between Progressive and Non-Progressive Chronic Kidney Disease
Associate Advisor
Other advisors: Dr Robert Ellis, Associate Professor Ross Francis
-
2021
Doctor Philosophy
Clinical Biobanking and the Distinguishing Risk of Progressive Chronic Kidney Disease Study
Associate Advisor
-
2020
Doctor Philosophy
Exploring Resistance of Renal Cell Carcinoma to Sunitinib Therapy
Associate Advisor
Other advisors: Professor Hemamali Samaratunga, Honorary Professor Li Li
-
2020
Doctor Philosophy
The role of the adipose tissue microenvironment in kidney cancer
Associate Advisor
Other advisors: Professor David Johnson, Dr Sumaira Hasnain
-
2016
Doctor Philosophy
Bioactive compounds from Australian Blacklip Abalone (Haliotis rubra) processing waste
Associate Advisor
-
2009
Doctor Philosophy
Targeting genes for identification and treatment of renal cell carcinoma
Associate Advisor
Other advisors: Professor David Johnson
Media
Enquiries
For media enquiries about Associate Professor David Vesey's areas of expertise, story ideas and help finding experts, contact our Media team: